Team:ESBS-Strasbourg/Results/Modelling
From 2010.igem.org
(Difference between revisions)
(6 intermediate revisions not shown) | |||
Line 352: | Line 352: | ||
</li> | </li> | ||
<li> | <li> | ||
- | <p><br/><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Results"> | + | <p><br/><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Results/Biobricks"> |
RESULTS</a></p> | RESULTS</a></p> | ||
<ul> | <ul> | ||
Line 363: | Line 363: | ||
<li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Results/Modelling"> | <li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Results/Modelling"> | ||
Modeling</a></li> | Modeling</a></li> | ||
- | + | ||
</ul> | </ul> | ||
Line 370: | Line 370: | ||
</li> | </li> | ||
<li> | <li> | ||
- | <p><br/><a | + | <p><br/><a> |
NOTEBOOK</a></p> | NOTEBOOK</a></p> | ||
<ul> | <ul> | ||
Line 377: | Line 377: | ||
<li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Notebook/Microfluidics"> | <li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Notebook/Microfluidics"> | ||
Microfluidics</a></li> | Microfluidics</a></li> | ||
+ | <li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Results/Device">Lighting device</a></li> | ||
<li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Notebook/Labbook"> | <li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Notebook/Labbook"> | ||
Lab-book</a></li> | Lab-book</a></li> | ||
Line 388: | Line 389: | ||
HUMAN PRACTICE</a></p> | HUMAN PRACTICE</a></p> | ||
<ul> | <ul> | ||
- | <li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Humanpractice | + | <li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Humanpractice#organisation"> |
Organisation</a></li> | Organisation</a></li> | ||
- | <li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Humanpractice | + | <li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Humanpractice#survey"> |
Survey</a></li> | Survey</a></li> | ||
- | <li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Humanpractice | + | <li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Humanpractice#video"> |
The ClpX video</a></li> | The ClpX video</a></li> | ||
- | <li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Humanpractice | + | <li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Humanpractice#game"> |
The ClpX game</a></li> | The ClpX game</a></li> | ||
- | <li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/ | + | <li><a href="https://2010.igem.org/Team:ESBS-Strasbourg/Humanpractice#safety"> |
Project Safety</a></li> | Project Safety</a></li> | ||
Line 409: | Line 410: | ||
</li> | </li> | ||
</ul> | </ul> | ||
+ | </div> | ||
</div> | </div> | ||
</div> | </div> | ||
Line 488: | Line 490: | ||
<td width="10" rowspan=7 bgcolor="#222222"> | <td width="10" rowspan=7 bgcolor="#222222"> | ||
</div> | </div> | ||
- | + | <div id="windowbox" style="position:fixed; top:50%; left:20px; width:11%;"> | |
+ | <span style="color:ivory;"> | ||
+ | | ||
+ | <a href="https://2010.igem.org/Team:ESBS-Strasbourg/science"> | ||
+ | <img border="0" src="https://static.igem.org/mediawiki/2010/d/da/ESBS-Strasbourg-Clpx.gif" width="70" height="85" ></a> | ||
+ | <br> | ||
+ | Let me guide you</span> | ||
<td width="800" bgcolor="#414141"> | <td width="800" bgcolor="#414141"> | ||
<br> | <br> | ||
Line 501: | Line 509: | ||
<div class="desc"> | <div class="desc"> | ||
<br> | <br> | ||
- | To automate the process of creation of new synthetic bio-systems | + | To automate the process of creation of new synthetic bio-systems, it is interesting to develop a specific design flow like the one we use in microelectronics. One of the main assets in microelectronic design flow for digital systems is the ability to describe a system at different levels of abstraction. |
<br><br> | <br><br> | ||
- | For our system we | + | For our system, we focused the modeling on two different level of abstraction. The first one is a high-level model and the second one is a low-level model. For each model we show the simulation results and, as a conclusion, we discuss the potential of the models we proposed. |
</div> | </div> | ||
<br> | <br> | ||
Line 521: | Line 529: | ||
<div class="desc"> | <div class="desc"> | ||
<br> | <br> | ||
- | As in digital electronics, multiple abstraction levels can be defined. The highest consists in the function of the system. This model, also called logical model, because it is based on logical equations, is a high level model. It is interesting to use high-level models, with fast simulations, to validate the concept of a bio-system. | + | As in digital electronics, multiple abstraction levels can be defined. The highest one consists in the function of the system. This model, also called logical model, because it is based on logical equations, is a high level model. It is interesting to use high-level models, with fast simulations, to validate the concept of a bio-system. |
<br> | <br> | ||
<br> | <br> | ||
Line 531: | Line 539: | ||
<br> | <br> | ||
<br> | <br> | ||
- | Based on these specifications, we deduce a group of logical equations. To | + | Based on these specifications, we deduce a group of logical equations. To create the model we use VHDL language, which is a hardware description language (HDL). The following VHDL code corresponds to our model: |
<br> | <br> | ||
<br> | <br> | ||
Line 537: | Line 545: | ||
<br> | <br> | ||
<br> | <br> | ||
- | We simulate this VHDL code with Dolphin SMASH 5.12 and we obtain followings results: | + | We simulate this VHDL code with Dolphin SMASH 5.12 and we obtain the followings results: |
<br> | <br> | ||
<br> | <br> | ||
Line 543: | Line 551: | ||
<br> | <br> | ||
<br> | <br> | ||
- | We see that when the light has a 730 nm wavelength the TAG-protein is not degraded. When the light | + | We see that when the light has a 730 nm wavelength the TAG-protein is not degraded. When the light reaches 660 nm, the TAG-protein is degraded after a 10 second delay, which corresponds to the time of the phytochrome activation and is arbitrarily fixed in the model. This delay was introduced after the low-level simulation to make this model fit the low-level ones. |
<br> | <br> | ||
<br> | <br> | ||
Line 571: | Line 579: | ||
<br> | <br> | ||
<br> | <br> | ||
- | The signal flow model is a low-level model. This kind of model is used to predict its behavior with accuracy and is based on equations to compute different concentrations. All biological mechanisms are based on chemical equations linking the concentration of chemical species involved. These chemical equations can be transformed into ordinary differential equations (ODEs), which are integrated to the model. | + | The signal flow model is a low-level model. This kind of model is used to predict its behavior with accuracy and is based on equations to compute different concentrations. All biological mechanisms are based on chemical equations linking the concentration of chemical species involved to each other. These chemical equations can be transformed into ordinary differential equations (ODEs), which are integrated to the model. |
<br> | <br> | ||
<br> | <br> | ||
- | First we will see a presentation of the system and the different interactions between states. Then we will explain the biological equations used to make the model and | + | First we will see a presentation of the system and the different interactions between states. Then we will explain the biological equations used to make the model and we will show simulation results for each part of the system. |
<br> | <br> | ||
<br> | <br> | ||
- | <div class="heading">b. | + | <div class="heading">b. System's presentation</div> |
<br> | <br> | ||
<br> | <br> | ||
- | Our system is | + | Our system is made up of a block named PCC (including the Phytochrome, ClpX and ClpP) and an other block, the DAS_GPF_ PIF chain where GFP is the TAG protein which is used to illustrate the mechanism. This system can be boiled down to the following four states scheme: |
<br> | <br> | ||
<br> | <br> | ||
Line 586: | Line 594: | ||
<br> | <br> | ||
<br> | <br> | ||
- | The first state is the state where | + | The first state is the state where PCC and DAS_GFP_PIF are free. Then PCC can form a complex with DAS, called PCC_DAS, with k<sub>1,0</sub> the coefficient of this complexation, or with PIF, called PCC_PIF, with k<sub>0,1</sub> the coefficient of this complexation. The last state is the PCC_DAS_PIF complex which is reached from PCC_DAS state by the complexation coefficient k<sub>0,1</sub>*c<sub>1,1</sub> or from PCC_PIF by k<sub>1,0</sub>*c<sub>1,1</sub>, where c<sub>1,1</sub> is the the coupling factor between the two sites of complexation. |
<br> | <br> | ||
<br> | <br> | ||
- | The TAG protein can only be degraded in | + | The TAG protein can only be degraded in PCC_DAS or PCC_DAS_PIF conformation, because DAS must be linked to launch the protein degradation process. This is why there are single arrows between states PCC and PCC_DAS and between PCC_PIF and PCC_DAS_PIF. |
<br> | <br> | ||
<br> | <br> | ||
Line 598: | Line 606: | ||
<br> | <br> | ||
<br> | <br> | ||
- | k<sub>1,0</sub> is very small so the formation of | + | k<sub>1,0</sub> is very small so the formation of PCC_DAS is scarce. k<sub>0,1</sub> is a coefficient which depends on the light's wavelength and this variance corresponds to the different physical structures of the PIF receptor (active or passive). With a 660 nm red light, PIF receptor is active and this coefficient is high but with a 730 nm infra-red light, PIF receptor is inactive and k<sub>0,1</sub> becomes very small. So to model this coefficient we use a Gaussian function centered on 660: |
<br> | <br> | ||
<br> | <br> | ||
Line 610: | Line 618: | ||
<br> | <br> | ||
<br> | <br> | ||
- | To find the ODEs for the different reactions of complexation brought into play, we start with a simple complexation between two species A and B: | + | To find the ODEs for the different reactions of complexation brought into play, we start with a simple complexation between two species, A and B: |
<br> | <br> | ||
<br> | <br> | ||
Line 616: | Line 624: | ||
<br> | <br> | ||
<br> | <br> | ||
- | where k<sub>on</sub> is the coefficient of the complex’s formation and k<sub>off</sub> the coefficient of the complex’s dissociation. The ODE of this reaction which gives the concentration of the complex AB is the following: | + | where k<sub>on</sub> is the coefficient of the complex’s formation and k<sub>off</sub> the coefficient of the complex’s dissociation. The ODE of this reaction which gives the concentration of the complex AB is the following one: |
<br> | <br> | ||
<br> | <br> | ||
Line 622: | Line 630: | ||
<br> | <br> | ||
<br> | <br> | ||
- | k<sub>degr</sub> is | + | k<sub>degr</sub> is only the constant of natural degradation of the complex. Using the same principle, we deduced the following equations for our system: |
<br> | <br> | ||
<br> | <br> | ||
Line 643: | Line 651: | ||
<br> | <br> | ||
<br> | <br> | ||
- | where k<sub>tr</sub> is the kinetic constant of transcription, K<sub>p</sub> the Hill’s constant representing strength of the activator or repressor, n<sub>p</sub> the Hill’s coefficient (positive for an activator and negative for a repressor) and d<sub>mRNA</sub> the degradation’s coefficient of mRNA. | + | where k<sub>tr</sub> is the kinetic constant of transcription, K<sub>p</sub> the Hill’s constant representing the strength of the activator or repressor, n<sub>p</sub> the Hill’s coefficient (positive for an activator and negative for a repressor) and d<sub>mRNA</sub> the degradation’s coefficient of mRNA. |
<br> | <br> | ||
<br> | <br> | ||
- | + | The same way, the synthesis of P protein from mRNA is defined by: | |
<br> | <br> | ||
<br> | <br> | ||
Line 655: | Line 663: | ||
<br> | <br> | ||
<br> | <br> | ||
- | For each species, | + | For each species, PCC, PIF and DAS, we use this mechanism to compute the species concentration produced, respectively PCC_prod, PIF_prod and DAS_prod. We must now compute the effective concentration of these species with these equations: |
<br> | <br> | ||
<br> | <br> | ||
Line 661: | Line 669: | ||
<br> | <br> | ||
<br> | <br> | ||
- | + | where PIF_l and DAS_l are the concentrations of PIF and DAS linked to the DAS_GFP_PIF chain already complexed at the other boundary (respectively DAS and PIF). We obtain the same equation for the different species. This is because we compute separately DAS, PIF and PCC’s concentrations for the complexation mechanism but we do have the same DAS_GFP_PIF free chain concentration as the free phytochrome concentration. So for the simulation results we just show the PCC and the DAS_GFP_PIF concentration because DAS and PIF concentrations are the same: | |
<br> | <br> | ||
<br> | <br> | ||
Line 670: | Line 678: | ||
<br> | <br> | ||
<br> | <br> | ||
- | The last but the most important concentration to show is TAG protein | + | The last but the most important concentration to show is the TAG protein's (GFP) concentration. First we compute the concentration of GFP produced, GFP_prod, with the same mechanism introduced in the previous part. Then, the concentration of PCC fixed GFP (ready to be degraded), GFP_l, is given by: |
<br> | <br> | ||
<br> | <br> | ||
Line 676: | Line 684: | ||
<br> | <br> | ||
<br> | <br> | ||
- | Finally we obtain the effective concentration of GFP | + | Finally we obtain the effective concentration of GFP with the following equation, including the degradation (with d<sub>GFP</sub> degradation coefficient) of the fixed GFP: |
<br> | <br> | ||
<br> | <br> | ||
Line 686: | Line 694: | ||
<br> | <br> | ||
<center><img src="https://static.igem.org/mediawiki/2010/c/c1/Lowlevel_simus_3.png" width="700px"></center> | <center><img src="https://static.igem.org/mediawiki/2010/c/c1/Lowlevel_simus_3.png" width="700px"></center> | ||
+ | <br> | ||
+ | <br> | ||
+ | We have seen that this model is accurate but it has some drawbacks too. It is based on ODEs so it requires the use of a numerical solver, leading to slow simulations. It depends on parameters that should be estimated with experiments and the more the parameters are accurate, the more the simulations are close to real cell behavior. | ||
<br> | <br> | ||
<br> | <br> | ||
Line 703: | Line 714: | ||
<div class="heading">4. Conclusion</div> | <div class="heading">4. Conclusion</div> | ||
<div class="desc"> | <div class="desc"> | ||
+ | <br> | ||
+ | <br> | ||
+ | The first simulation we have introduced is made at high-level and is compared to the high-level model previously obtained in the following scheme: | ||
<br> | <br> | ||
<br> | <br> | ||
<center><img src="https://static.igem.org/mediawiki/2010/8/8d/Lowlevel_simus_4.png" width="700px"></center> | <center><img src="https://static.igem.org/mediawiki/2010/8/8d/Lowlevel_simus_4.png" width="700px"></center> | ||
+ | <br> | ||
+ | <br> | ||
+ | The delay in the high-level model was included after the low-level simulation to make both models match. | ||
+ | <br> | ||
+ | <br> | ||
+ | The modeling part of our system takes advantage of microelectronics knowledge, which has proven itself, and resumes the main steps of the design flow used in this field to design a system. | ||
+ | <br> | ||
+ | <br> | ||
+ | Each model has its own interest that we have seen previously, but it is the possibility to use them jointly that may be relevant, in order to simulate systems quickly with different levels of detail depending on the need (sensitive part or not, already validated or not ...). | ||
+ | <br> | ||
+ | <br> | ||
+ | We did not have enough time to study the parameters extraction. Using characterization software like IC-CAP on our system, we still have to extract the parameters of the model to make it match with the real biological system. | ||
<br> | <br> | ||
<br> | <br> |
Latest revision as of 16:37, 27 October 2010
{|
>